List of events that could affect this stock. Analyst estimates, including acst earnings per share estimates and analyst recommendations.
Page 4 Ideas And Forecasts On Acasti Pharma Inc Nasdaqacst Tradingview
Marketbeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.

Acasti pharma stock price target. Volume fell on the last day along with the stock, which is actually a good sign as. Acst updated stock price target summary. Get the hottest stocks to trade every day before the market opens 100% free.
The company report on december 24, 2020 that acasti pharma unaware of any material change. Is set at 0.09, with the price to sales ratio for acst stock in the period of the last 12 months amounting to 1754.14. Get the stock price and latest news for acst and start trading today with zero commissions.
The price target was changed from $2.00 to. Looking to buy acasti pharma stock? In terms of volatility of its share price, acst is more volatile than 99.45% of stocks we're observing.
14, 2020 at 8:56 a.m. Acasti pharma stock price target cut to $2 from $8 at b. Based on data from november 24, 2021 at 22:29, the general acasti pharma, inc.
Nasdaq updated dec 3, 2021 12:35 am acst 1.29 0.02 (1.58%). Volume has increased on the last day by 373 thousand. Has the lowest price target set, forecasting a price of $10,000,000.00 for acasti pharma in.
Since then, acst stock has decreased by 58.8% and is now trading at $1.27. The average true range (atr) for acasti pharma inc. Marketbeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Analysts gave the acasti pharma inc. The average analyst price target of acst is higher than 1.54% of pharmaceutical products stocks. Acst has a lower variance in analysts' estimates than just about 100% of all us stocks.
On the other hand, acasti pharma's target price is what analysts think the stock is worth or could sell for in the future. Acst has a higher upside potential (average analyst target price relative to current price) than 14.31% of pharmaceutical products stocks. Price prediction sentiment is bullish, with 20 technical analysis indicators signaling bullish signals, and 6 signaling bearish signals.
With a price/sales ratio of 316.34, acasti pharma inc has a higher such ratio than 98.49% of stocks in our set. The current price of acasti pharma is the price at which acasti pharma is currently trading. Find the latest acasti pharma, inc.
Price prediction was last updated on november 24, 2021 at 22:29. The new note on the price target was released on july 06, 2020, representing the official price target for acasti pharma inc. Analyst ratings, historical stock prices, earnings estimates & actuals.
They're working on a phase two test of a new drug, but the results are delayed, which has hammered the stock by half, though it's moved up 16% today. Acasti pharma target price projection acasti pharma's current and average target prices are 1.38 and 0.00, respectively. (acst) stock price quote with breaking news, financials, statistics, charts and more.
(acst) stock a consensus recommendation rating of a hold, calculated at a mean rating of 2.00.
Acst Stock Price And Chart Nasdaqacst Tradingview
J5ta9gm6bfmbbm
3 Healthcare Stocks With Big Catalysts In January Nasdaq
Earnings Whisper Number For Acst Acasti Pharma
Acasti Pharma Inc - Class A Price Acst Forecast With Price Charts
3 Beaten-down Biotech Stocks With 50 Upside Potential Nasdaq
Acasti Pharma Inc Acst August 27 2021 Stock Price Analysis Forecast List23 Latest Us News Breaking World News
Acasti Pharma Inc - Class A Price Acst Forecast With Price Charts
Acasti Pharma Stock Loses A Wall Street Supporter
From Almost Every Angle Acasti Pharma Stock Is Too Risky Investorplace
3 Penny Stocks On Robinhood To Buy Under 1 Right Now
Acasti Pharma Incs Cveacst Shift From Loss To Profit
Acst Institutional Ownership - Acasti Pharma Inc Stock
Acasti Pharmaceuticals Countdown Is On To Phase 3 Trial Results - Align Research
Page 4 Ideas And Forecasts On Acasti Pharma Inc Nasdaqacst Tradingview
Acst Price Target Analyst Ratings Predictions Acasti Pharma
Acasti Pharma Inc Acst Stock Price Ca00430k8730 Marketscreener
Acasti Pharma Nasdaqacst Stock Price News Charts - Benzinga
3 Healthcare Stocks With Big Catalysts In January Nasdaq
Comments
Post a Comment